News All Asylia News Nirogy News Press Release Sporos News Stellanova News Tvardi News Sporos News Sporos Launches with $38.1 Million Series A Financing May 6, 2021 Read More → Nirogy News Nirogy Therapeutics to Present at AACR Annual Meeting 2021 April 7, 2021 Read More → Asylia News JLABS @ TMC and Asylia Therapeutics on Navigating a Powerful Tool: The Human Immune System February 17, 2021 Read More → Nirogy News Nirogy Therapeutics Launches with $16.5 Million Series A Financing January 26, 2021 Read More → Tvardi News Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum December 28, 2020 Read More → Asylia News New Company Asylia Therapeutics Finalizes Exclusive Worldwide License Agreement October 9, 2020 Read More → Tvardi News Tvardi Therapeutics Announces Publication Demonstrating TTI-101 as a Therapeutic Option for Treatment-Resistant Breast Cancers October 4, 2020 Read More → Tvardi News Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research June 24, 2020 Read More → Asylia News Asylia Therapeutics Moves into JLABS @TMC June 6, 2020 Read More → Tvardi News KRLD Radio Interview: Some Covid Survivors Face Long-Term Consequences June 3, 2020 Read More → Asylia News CPRIT Awards $3 Million to Asylia Therapeutics May 11, 2020 Read More → Asylia News Heat Shock Protein-70 (HSP70) is an Essential Component of Anti-Tumor Immunity May 2, 2020 Read More →
